Resultados de la búsqueda 461-470 of 89635 for Cancer

  1. Cáncer de mama recurrente - Síntomas y causas - Mayo Clinic

    Cáncer de mama inflamatorio. Las personas con cáncer de mama inflamatorio tienen un mayor riesgo de recurrencia local. Falta de terapia endocrina para el cáncer ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. ... Rituximab is a monoclonal antibody that may interfere ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able to ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

  7. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    ... cancer treatments for patients with relapsed/refractory multiple myeloma (RRMM). ... Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria ...